BALANCE SHEETS - USD ($)	Mar. 31, 2026	Dec. 31, 2025
Current Assets:
Cash and cash equivalents	$ 18,735,035	$ 20,080,652
Prepaid expenses	41,217	14,700
Total Current Assets	18,776,252	20,095,352
Cash held in segregated account	5,001,000	5,001,000
Total Assets	23,777,252	25,096,352
Current Liabilities:
Accrued expenses	619,485	269,096
Directors compensation payable	225,000	225,000
Total Current Liabilities	844,485	494,096
Total Liabilities	44,117,310	44,773,777
Stockholders' Equity/(Deficit)
Common Stock, $0.0001 par value; 3,000,000,000 shares authorized and 422,533 issued and outstanding at March 31, 2026 and December 31, 2025	42	42
Additional paid-in capital	4,225,288	4,225,288
Accumulated deficit	(24,565,388)	(23,902,755)
Total Stockholders' Equity/(Deficit)	(20,340,058)	(19,677,425)
Total Liabilities And Stockholders' Equity/(Deficit)	23,777,252	25,096,352
Advisory Warrants [Member]
Current Liabilities:
Warrants and rights outstanding	2,000,000	3,000,000
Sponsor Warrants [Member]
Current Liabilities:
Warrants and rights outstanding	$ 41,272,825	$ 41,279,681

Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Name:	us-gaap_AccruedLiabilitiesCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.